IRONWOOD PHARMACEUTICALS INC's ticker is IRWD and the CUSIP is 46333X108. A total of 205 filers reported holding IRONWOOD PHARMACEUTICALS INC in Q4 2020. The put-call ratio across all filers is 0.02 and the average weighting 0.2%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2021 | $718,000 | -68.4% | 55,000 | -68.8% | 0.01% | -73.3% |
| Q2 2021 | $2,272,000 | -8.4% | 176,548 | -20.4% | 0.03% | -43.4% |
| Q1 2021 | $2,480,000 | +335.1% | 221,700 | +342.4% | 0.05% | +307.7% |
| Q4 2020 | $570,000 | -34.9% | 50,113 | -48.6% | 0.01% | -35.0% |
| Q3 2020 | $876,000 | -53.4% | 97,500 | -46.5% | 0.02% | -68.3% |
| Q2 2020 | $1,880,000 | +314.1% | 182,300 | +305.1% | 0.06% | +142.3% |
| Q1 2020 | $454,000 | -78.5% | 45,000 | -71.7% | 0.03% | -63.4% |
| Q4 2019 | $2,116,000 | +134.9% | 159,000 | +51.4% | 0.07% | +51.1% |
| Q3 2019 | $901,000 | -45.3% | 105,000 | -30.2% | 0.05% | -43.4% |
| Q2 2019 | $1,646,000 | -28.2% | 150,400 | -25.7% | 0.08% | -34.1% |
| Q1 2019 | $2,291,000 | +10.6% | 202,400 | +1.2% | 0.13% | -23.6% |
| Q4 2018 | $2,072,000 | – | 200,000 | – | 0.16% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Sarissa Capital Management LP | 16,390,000 | $172,422,800 | 22.05% |
| 13D Management LLC | 533,562 | $5,613,073 | 2.85% |
| Quantedge Capital Pte Ltd | 541,200 | $5,693,424 | 2.22% |
| Price Jennifer C. | 520,000 | $5,470,400 | 1.74% |
| Tamarack Advisers, LP | 210,000 | $2,209,200 | 0.81% |
| Intrinsic Value Partners, LLC | 51,605 | $542,885 | 0.73% |
| Brown Capital Management | 3,933,933 | $41,384,975 | 0.62% |
| Old West Investment Management, LLC | 75,219 | $791,303 | 0.43% |
| EMC Capital Management | 43,315 | $456 | 0.38% |
| Hillsdale Investment Management Inc. | 420,617 | $4,424,891 | 0.38% |